Multiple studies have shown the that levels of C3 and C3aR are elevated in the brain in ageing and Alzheimer's disease (AD) mouse models, as well as in patients with AD, and that their inactivation prevents age-related functional decline and AD neuropathology (20, 21, 22). The gene discussed is C3AR1; the disease is early-onset autosomal dominant Alzheimer disease.